Read More Healthcare Industry News CooperCompanies Q2 FY2025 results: Revenue tops $1bn, but stock hits 52-week low Despite 14% EPS growth and a strong lens and surgical portfolio, CooperCompanies stock falls to 52-week low. Find out what’s driving investor sentiment. byPallavi MadhirajuMay 30, 2025